Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Fibrogen Inc (FGEN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Fibrogen Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 921299.
Total stock buying since 2015: $1,558,665.
Total stock sales since 2015: $220,602,753.
Total stock option exercises since 2015: $24,738,459.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 468,567 | $275,139 | 0 | $0 | 0 | $0 |
| 2024 | 50,000 | $95,450 | 0 | $0 | 0 | $0 |
| 2023 | 0 | $0 | 219,134 | $4,071,990 | 0 | $0 |
| 2022 | 0 | $0 | 6,943 | $107,123 | 0 | $0 |
| 2021 | 3,100 | $35,743 | 49,099 | $1,598,270 | 41,999 | $522,130 |
| 2020 | 27,800 | $988,883 | 146,666 | $5,897,563 | 161,886 | $3,059,897 |
| 2019 | 0 | $0 | 1,029,307 | $48,336,364 | 655,059 | $5,835,259 |
| 2018 | 0 | $0 | 1,359,531 | $73,772,269 | 808,272 | $6,849,677 |
| 2017 | 3,500 | $163,450 | 1,438,950 | $55,095,822 | 1,011,028 | $5,035,041 |
| 2016 | 0 | $0 | 880,582 | $17,119,568 | 456,814 | $1,757,502 |
| 2015 | 0 | $0 | 564,264 | $14,603,784 | 355,358 | $1,678,953 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-12-28 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 20.69 | 391,020 |
| 2016-12-28 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,089 | 4.03 | 56,708 |
| 2016-12-27 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 20.79 | 392,910 |
| 2016-12-27 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-12-19 | Neff Thomas B (Chief Executive Officer) | Option Ex | 24,844 | 4.03 | 99,997 |
| 2016-12-16 | Riggs Rory B (Director) | Sale | 20,000 | 20.87 | 417,320 |
| 2016-12-14 | Yu K Peony (Chief Medical Officer) | Sale | 2,344 | 20.65 | 48,403 |
| 2016-12-13 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 21.20 | 400,658 |
| 2016-12-13 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-12-12 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 21.78 | 411,620 |
| 2016-12-12 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-12-12 | Cotroneo Pat (VP, Finance and CFO) | Sale | 2,344 | 22.05 | 51,685 |
| 2016-11-29 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 22.86 | 432,031 |
| 2016-11-29 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-11-28 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 22.74 | 429,763 |
| 2016-11-28 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-11-18 | Kearns Thomas F Jr (Director) | Sale | 13,000 | 22.47 | 292,136 |
| 2016-11-18 | Kearns Thomas F Jr (Director) | Option Ex | 13,000 | 4.03 | 52,325 |
| 2016-11-17 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 22.22 | 419,935 |
| 2016-11-17 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-11-17 | Kearns Thomas F Jr (Director) | Sale | 5,000 | 22.21 | 111,030 |
| 2016-11-17 | Kearns Thomas F Jr (Director) | Option Ex | 5,000 | 4.03 | 20,125 |
| 2016-11-16 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 22.36 | 422,581 |
| 2016-11-16 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-11-08 | Yu K Peony (Chief Medical Officer) | Option Ex | 4,700 | 4.72 | 22,207 |
| 2016-11-04 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 1,643 | 2.90 | 4,764 |
| 2016-11-01 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 16.84 | 318,259 |
| 2016-11-01 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-10-31 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 16.67 | 315,046 |
| 2016-10-31 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-10-19 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 17.56 | 331,866 |
| 2016-10-19 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-10-18 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 17.94 | 339,048 |
| 2016-10-18 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-10-04 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 20.67 | 390,642 |
| 2016-10-04 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-10-03 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 20.55 | 388,374 |
| 2016-10-03 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-09-21 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 21.52 | 406,706 |
| 2016-09-21 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-09-20 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 21.80 | 411,998 |
| 2016-09-20 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-09-14 | Yu K Peony (Chief Medical Officer) | Sale | 2,345 | 18.66 | 43,757 |
| 2016-09-12 | Cotroneo Pat (VP, Finance and CFO) | Sale | 2,345 | 18.22 | 42,725 |
| 2016-09-09 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 18.83 | 355,868 |
| 2016-09-09 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-09-08 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 19.14 | 361,726 |
| 2016-09-08 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-08-26 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 17.81 | 336,591 |
| 2016-08-26 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-08-25 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 17.95 | 339,331 |
| 2016-08-25 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-07-27 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 18.41 | 347,892 |
| 2016-07-27 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-07-26 | Neff Thomas B (Chief Executive Officer) | Sale | 18,899 | 18.43 | 348,214 |
| 2016-07-26 | Neff Thomas B (Chief Executive Officer) | Option Ex | 14,091 | 4.03 | 56,716 |
| 2016-07-13 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.10 | 230,850 |
| 2016-07-12 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.81 | 240,434 |
| 2016-06-29 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 16.17 | 218,295 |
| 2016-06-28 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 16.04 | 216,540 |
| 2016-06-15 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 16.49 | 222,614 |
| 2016-06-15 | Cotroneo Pat (VP, Finance and CFO) | Sale | 1,796 | 16.49 | 29,616 |
| 2016-06-14 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 16.47 | 222,344 |
| 2016-06-10 | Yu K Peony (Chief Medical Officer) | Sale | 2,344 | 17.96 | 42,098 |
| 2016-06-03 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 18.81 | 253,934 |
| 2016-06-02 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 19.16 | 258,660 |
| 2016-05-20 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.88 | 241,380 |
| 2016-05-19 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.79 | 240,097 |
| 2016-05-16 | Cotroneo Pat (VP, Finance and CFO) | Sale | 6,107 | 17.60 | 107,483 |
| 2016-05-16 | Yu K Peony (Chief Medical Officer) | Sale | 6,107 | 17.60 | 107,483 |
| 2016-05-03 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.61 | 237,735 |
| 2016-05-02 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 17.95 | 242,325 |
| 2016-04-20 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 19.75 | 266,625 |
| 2016-04-19 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 20.21 | 272,835 |
| 2016-04-05 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 21.00 | 283,432 |
| 2016-04-04 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 21.30 | 287,550 |
| 2016-04-01 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,750 | 21.29 | 228,835 |
| 2016-04-01 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,750 | 3.92 | 42,193 |
| 2016-03-22 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 18.87 | 254,745 |
| 2016-03-21 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 18.73 | 252,922 |
| 2016-03-16 | Tamura Toshinari (Director) | Option Ex | 48,000 | 2.72 | 130,416 |
| 2016-03-08 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 19.41 | 262,102 |
| 2016-03-07 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 20.11 | 271,417 |
| 2016-03-01 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,750 | 17.04 | 183,190 |
| 2016-03-01 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,750 | 3.44 | 37,001 |
| 2016-02-23 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 18.68 | 252,247 |
| 2016-02-22 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 20.05 | 270,675 |
| 2016-02-10 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 15.48 | 208,980 |
| 2016-02-09 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 15.33 | 206,955 |
| 2016-02-05 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 3,627 | 2.90 | 10,518 |
| 2016-02-05 | Yu K Peony (VP, Clinical Development) | Option Ex | 10,500 | 4.72 | 49,612 |
| 2016-01-29 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 19.88 | 268,312 |
| 2016-01-28 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 19.43 | 262,372 |
| 2016-01-22 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.90 | 29,000 |
| 2016-01-21 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 4,000 | 2.90 | 11,600 |
| 2016-01-21 | Kearns Thomas F Jr (Director) | Sale | 1,572 | 22.08 | 34,709 |
| 2016-01-14 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.35 | 315,225 |
| 2016-01-13 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 24.11 | 325,417 |
| 2015-12-28 | Routti Jorma (Director) | Option Ex | 20,000 | 3.01 | 60,260 |
| 2015-12-24 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 30.81 | 120,159 |
| 2015-12-23 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 30.93 | 417,555 |
| 2015-12-23 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 30.94 | 120,666 |
| 2015-12-22 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 29.61 | 399,667 |
| 2015-12-15 | Cotroneo Pat (VP, Finance and CFO) | Sale | 837 | 28.95 | 24,231 |
| 2015-12-11 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 29.39 | 396,832 |
| 2015-12-10 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 29.94 | 404,190 |
| 2015-12-10 | Yu K Peony (VP, Clinical Development) | Sale | 1,093 | 28.96 | 31,653 |
| 2015-12-08 | Madero Miguel (Director) | Sale | 40,386 | 30.49 | 1,231,369 |
| 2015-12-08 | Madero Miguel (Director) | Option Ex | 84,000 | 8.05 | 676,368 |
| 2015-12-04 | Rosenkranz Roberto Pedro (Director) | Option Ex | 7,000 | 4.42 | 30,975 |
| 2015-12-03 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 1,300 | 2.90 | 3,770 |
| 2015-11-30 | Yu K Peony (VP, Clinical Development) | Sale | 4,656 | 30.00 | 139,680 |
| 2015-11-25 | Cotroneo Pat (VP, Finance and CFO) | Sale | 5,000 | 30.00 | 150,000 |
| 2015-11-25 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 5,000 | 2.35 | 11,750 |
| 2015-11-25 | Yu K Peony (VP, Clinical Development) | Sale | 344 | 30.00 | 10,320 |
| 2015-11-24 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 28.82 | 389,002 |
| 2015-11-24 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 28.82 | 112,417 |
| 2015-11-23 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 28.11 | 379,485 |
| 2015-11-23 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 28.02 | 109,278 |
| 2015-11-17 | Yu K Peony (VP, Clinical Development) | Sale | 5,000 | 28.00 | 140,000 |
| 2015-11-13 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.90 | 29,000 |
| 2015-11-10 | Yu K Peony (VP, Clinical Development) | Sale | 2,500 | 26.23 | 65,575 |
| 2015-11-09 | Yu K Peony (VP, Clinical Development) | Sale | 2,500 | 25.00 | 62,500 |
| 2015-11-02 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,000 | 23.45 | 234,500 |
| 2015-11-02 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.90 | 29,000 |
| 2015-10-30 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 24.06 | 324,783 |
| 2015-10-29 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 24.25 | 327,388 |
| 2015-10-21 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 23.56 | 91,891 |
| 2015-10-20 | Kearns Thomas F Jr (Director) | Sale | 3,900 | 24.56 | 95,787 |
| 2015-10-19 | Yu K Peony (VP, Clinical Development) | Sale | 5,000 | 24.00 | 120,000 |
| 2015-10-19 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,000 | 23.00 | 230,000 |
| 2015-10-19 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-10-16 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 22.21 | 299,902 |
| 2015-10-16 | Yu K Peony (VP, Clinical Development) | Sale | 2,500 | 22.42 | 56,050 |
| 2015-10-15 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 21.41 | 289,102 |
| 2015-10-15 | Yu K Peony (VP, Clinical Development) | Sale | 2,500 | 20.50 | 51,250 |
| 2015-10-02 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 21.89 | 295,515 |
| 2015-10-01 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 21.36 | 288,360 |
| 2015-10-01 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,000 | 21.38 | 213,780 |
| 2015-10-01 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-09-18 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 29.05 | 392,175 |
| 2015-09-18 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.90 | 27,460 |
| 2015-09-17 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 29.04 | 391,972 |
| 2015-09-17 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.62 | 24,856 |
| 2015-09-15 | Cotroneo Pat (VP, Finance and CFO) | Sale | 1,093 | 27.95 | 30,549 |
| 2015-09-14 | Riggs Rory B (Director) | Sale | 25,571 | 27.56 | 704,736 |
| 2015-09-11 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 1,340 | 2.90 | 3,886 |
| 2015-09-11 | Madero Miguel (Director) | Sale | 20,600 | 27.66 | 569,796 |
| 2015-09-11 | Riggs Rory B (Director) | Sale | 24,429 | 28.40 | 693,856 |
| 2015-09-10 | Cotroneo Pat (VP, Finance and CFO) | Sale | 5,000 | 28.00 | 140,000 |
| 2015-09-10 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 5,000 | 2.35 | 11,750 |
| 2015-09-10 | Yu K Peony (VP, Clinical Development) | Sale | 1,093 | 27.84 | 30,430 |
| 2015-09-08 | Cotroneo Pat (VP, Finance and CFO) | Sale | 2,500 | 26.00 | 65,000 |
| 2015-09-08 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 3,190 | 2.62 | 8,373 |
| 2015-09-04 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 22.88 | 308,880 |
| 2015-09-04 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-09-03 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.25 | 313,875 |
| 2015-09-03 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-09-01 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,000 | 23.58 | 235,780 |
| 2015-09-01 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-08-17 | Madero Miguel (Director) | Option Ex | 12,000 | 4.03 | 48,300 |
| 2015-08-06 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.41 | 316,035 |
| 2015-08-06 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-08-05 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.82 | 321,556 |
| 2015-08-05 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-08-03 | Valone Frank H Md (Chief Medical Officer) | Sale | 10,000 | 23.37 | 233,730 |
| 2015-08-03 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 10,000 | 2.35 | 23,500 |
| 2015-07-27 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 1,400 | 2.90 | 4,060 |
| 2015-07-23 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 24.80 | 334,800 |
| 2015-07-23 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-07-22 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 24.62 | 332,370 |
| 2015-07-22 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-07-20 | Cotroneo Pat (VP, Finance and CFO) | Sale | 2,500 | 24.00 | 60,000 |
| 2015-07-20 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 2,500 | 2.35 | 5,875 |
| 2015-07-20 | Valone Frank H Md (Chief Medical Officer) | Sale | 1,000 | 23.70 | 23,702 |
| 2015-07-20 | Valone Frank H Md (Chief Medical Officer) | Option Ex | 1,000 | 2.35 | 2,350 |
| 2015-07-17 | Cotroneo Pat (VP, Finance and CFO) | Sale | 5,381 | 23.23 | 125,000 |
| 2015-07-09 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 22.13 | 298,755 |
| 2015-07-09 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-07-08 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 22.08 | 298,080 |
| 2015-07-08 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-07-06 | Yu K Peony (VP, Clinical Development) | Sale | 5,381 | 22.70 | 122,121 |
| 2015-06-25 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.52 | 317,520 |
| 2015-06-25 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-06-24 | Neff Thomas B (Chief Executive Officer) | Sale | 13,500 | 23.72 | 320,179 |
| 2015-06-24 | Neff Thomas B (Chief Executive Officer) | Option Ex | 9,469 | 2.35 | 22,252 |
| 2015-06-12 | Cotroneo Pat (VP, Finance and CFO) | Option Ex | 12,000 | 2.90 | 34,800 |
| 2015-05-20 | Stern Julian N (Director) | Option Ex | 18,000 | 18.00 | 324,000 |
| 2015-05-15 | Yu K Peony (VP, Clinical Development) | Option Ex | 8,000 | 3.20 | 25,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of FGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Fibrogen Inc (symbol FGEN, CIK number 921299) see the Securities and Exchange Commission (SEC) website.